T3 · Product exporter position

Denmark exports of Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale (HS 300439)

See where Denmark stands in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale: export scale, destination breadth, market position, growth, and reported trade history.

Explore this product View destinations

Exporter DNKHS6 300439Latest year 2024Stable

Latest exports

$6.6BLatest observed lane total

Destination markets

97Reported active markets

Three-year growth

+0.2%Annualized change

Destination HHI

708Destination concentration

Weighted share

31.9%Reported market position

Exporter evidence

How strong is Denmark in Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale?

Reported exporter totals and calculated indicators for HS 300439. Values retain their observed coverage period.

Exporter scale

Latest exports$6.6B

Current 2024 exports$6.6B

Three-year average$6.9B

Historical peak$11.5B

Market position

Active destinations97

Destination HHI708

Weighted share31.9%

Share change+3 pp

Competitiveness

Three-year growth+0.2%

Volatility1.6

Maximum drawdown81.3%

TrendStable

Measure	Value	What it describes
Exporter	Denmark	Country represented by this profile
Latest observed exports	$6.6B	Sum of latest observed destination-lane values
Current 2024 exports	$6.6B	Common-year comparison where reported
Three-year growth	+0.2%	Annualized change in exporter totals
Five-year growth	+2.4%	Annualized change in exporter totals
Leading destination	CHN	Destination with the largest observed export value
Leading destination share	15.7%	Share of observed exporter totals
Destination concentration	708	HHI across destination markets
Weighted share change	+3 pp	Value-weighted latest change in market share
Limited-history lanes	15.6%	Share of lanes with shorter history

Destination markets

Where does Denmark sell medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale?

Leading destination observations ranked by reported export value, with market position and access context.

Destination	Latest exports	Market share	Growth	Access	Signal
China	$1.0B	34.8%	+65.1%	0.3% tariff	Accelerating
Brazil	$754.5M	61.6%	+71.8%	0.3% tariff	Accelerating
USA, Puerto Rico and US Virgin Islands	$600.9M	6.5%	-48.4%	0% tariff	Growing
United Kingdom	$542.0M	18.3%	+42.7%	FTA reported	Growing
Italy	$507.2M	30.7%	+71%	FTA reported	Accelerating
Japan	$478.4M	26.3%	+10.4%	FTA reported	Growing
Israel	$263.2M	62.5%	+52.4%	FTA reported	Accelerating
Switzerland, Liechtenstein	$227.9M	8.5%	+44.2%	FTA reported	Accelerating
Sweden	$184.8M	59.4%	+35.7%	FTA reported	Growing
Republic of Korea	$133.9M	28.2%	+75.4%	FTA reported	Accelerating
Poland	$125.4M	21.2%	+45.6%	FTA reported	Accelerating
Romania	$124.2M	46.8%	+119.9%	0.1% tariff	Accelerating
Norway	$120.2M	62.2%	+24.3%	FTA reported	Accelerating
United Arab Emirates	$113.8M	19.2%	+78.2%	0.1% tariff	Accelerating
Finland	$105.5M	64.2%	+9.7%	FTA reported	Growing

Destination

China

Latest exports: $1.0B
Market share: 34.8%
Growth: +65.1%
Access: 0.3% tariff
Signal: Accelerating

Destination

Brazil

Latest exports: $754.5M
Market share: 61.6%
Growth: +71.8%
Access: 0.3% tariff
Signal: Accelerating

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports: $600.9M
Market share: 6.5%
Growth: -48.4%
Access: 0% tariff
Signal: Growing

Destination

United Kingdom

Latest exports: $542.0M
Market share: 18.3%
Growth: +42.7%
Access: FTA reported
Signal: Growing

Destination

Italy

Latest exports: $507.2M
Market share: 30.7%
Growth: +71%
Access: FTA reported
Signal: Accelerating

Destination

Japan

Latest exports: $478.4M
Market share: 26.3%
Growth: +10.4%
Access: FTA reported
Signal: Growing

Destination

Israel

Latest exports: $263.2M
Market share: 62.5%
Growth: +52.4%
Access: FTA reported
Signal: Accelerating

Destination

Switzerland, Liechtenstein

Latest exports: $227.9M
Market share: 8.5%
Growth: +44.2%
Access: FTA reported
Signal: Accelerating

Destination

Sweden

Latest exports: $184.8M
Market share: 59.4%
Growth: +35.7%
Access: FTA reported
Signal: Growing

Destination

Republic of Korea

Latest exports: $133.9M
Market share: 28.2%
Growth: +75.4%
Access: FTA reported
Signal: Accelerating

Destination

Poland

Latest exports: $125.4M
Market share: 21.2%
Growth: +45.6%
Access: FTA reported
Signal: Accelerating

Destination

Romania

Latest exports: $124.2M
Market share: 46.8%
Growth: +119.9%
Access: 0.1% tariff
Signal: Accelerating

Destination

Norway

Latest exports: $120.2M
Market share: 62.2%
Growth: +24.3%
Access: FTA reported
Signal: Accelerating

Destination

United Arab Emirates

Latest exports: $113.8M
Market share: 19.2%
Growth: +78.2%
Access: 0.1% tariff
Signal: Accelerating

Destination

Finland

Latest exports: $105.5M
Market share: 64.2%
Growth: +9.7%
Access: FTA reported
Signal: Growing

Price intelligence

How does Denmark's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

United Arab Emirates: $33.3M / ton.

Lowest reported price

Saint Vincent and the Grenadines: $1.1K / ton.

Median price

$414.0K / ton across reported markets.

Export trend

Reported export history

Annual observations for Denmark and HS 300439 where available.

Year	Exports	Year-on-year change	Active destinations
2010	$1.4B	+44.2%	84
2011	$1.7B	+21.6%	95
2012	$2.0B	+13.6%	96
2013	$2.0B	+0.6%	98
2014	$2.1B	+8.6%	100
2015	$2.5B	+15.2%	94
2016	$3.0B	+21%	95
2017	$3.4B	+12.2%	95
2018	$4.3B	+28.4%	100
2019	$5.9B	+36.5%	92
2020	$6.7B	+13.6%	100
2021	$6.6B	-1.4%	101
2022	$6.9B	+4.8%	104
2023	$7.1B	+3.7%	103
2024	$6.6B	-7.5%	97

Exporter context

Denmark economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300439.

Denmark has reported exports of $123.1B and a trade balance of $4.5B in 2024.

Available structural indicators include 56.6% trade openness, 22.1% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Denmark medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.